Multiple sclerosis and related disorders
Retrospective review of lymphocyte changes when switching between fumarates in patients with multiple sclerosis.
Aimee Banks, Autumn Zuckerman, Josh DeClercq, Leena Choi, Katie R Cruchelow, Megan Schneider
Published: 202610.1016/j.msard.2026.106968
Abstract
BACKGROUND: When treating multiple sclerosis, lymphopenia is an established side effect of fumaric acids. Research demonstrating the impact of switching fumarates on lymphocyte counts is scarce. The objective of this study is to characterize the inci…
Preview only. Read the full abstract at the source